Global Huntington's Disease Therapeutics Market Insights, Forecast to 2025

2019-01-14 / 3900.00 / Pharma & Healthcare / 112 Pages

Description

Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. 
The demand for Huntington’s disease (HD) therapeutics as one of the primary growth factors for the Huntington’s disease therapeutics market. HD is equally prevalent in both males and females and affects people irrespective of their ethnicity. The disease symptoms may appear anytime in the individual’s life and the etiology is genetic. The person who inherits the mutated genes from their affected parents will probably suffer from the disease sometime in their lifetime.
The Americas is witnessing increasing incidences of HD. The availability of increased patient pool and the rise in government initiatives boost the research and development of novel therapeutics for the treatment of HD. The rising investments towards the launch of new drugs for the treatment of chorea will positively influence the growth of the Huntington’s disease therapeutics market in this region.
The global Huntington's Disease Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Huntington's Disease Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Huntington's Disease Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Huntington's Disease Therapeutics in these regions.
This research report categorizes the global Huntington's Disease Therapeutics market by top players/brands, region, type and end user. This report also studies the global Huntington's Disease Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma

Market size by Product
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Market size by End User
Hospitals
Clinics
Diagnostic Centers

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Huntington's Disease Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Huntington's Disease Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Huntington's Disease Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Huntington's Disease Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Huntington's Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Huntington's Disease Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Huntington's Disease Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by Product
1.4.2 Antidopaminergics
1.4.3 Anticonvulsants
1.4.4 Antipsychotics
1.4.5 Antidepressants
1.5 Market by End User
1.5.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Huntington's Disease Therapeutics Market Size
2.1.1 Global Huntington's Disease Therapeutics Revenue 2014-2025
2.1.2 Global Huntington's Disease Therapeutics Sales 2014-2025
2.2 Huntington's Disease Therapeutics Growth Rate by Regions
2.2.1 Global Huntington's Disease Therapeutics Sales by Regions
2.2.2 Global Huntington's Disease Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Huntington's Disease Therapeutics Sales by Manufacturers
3.1.1 Huntington's Disease Therapeutics Sales by Manufacturers
3.1.2 Huntington's Disease Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Huntington's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Huntington's Disease Therapeutics Revenue by Manufacturers
3.2.1 Huntington's Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Huntington's Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Huntington's Disease Therapeutics Price by Manufacturers
3.4 Huntington's Disease Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Huntington's Disease Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Huntington's Disease Therapeutics Sales by Product
4.2 Global Huntington's Disease Therapeutics Revenue by Product
4.3 Huntington's Disease Therapeutics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Huntington's Disease Therapeutics Breakdown Data by End User

6 North America
6.1 North America Huntington's Disease Therapeutics by Countries
6.1.1 North America Huntington's Disease Therapeutics Sales by Countries
6.1.2 North America Huntington's Disease Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Huntington's Disease Therapeutics by Product
6.3 North America Huntington's Disease Therapeutics by End User

7 Europe
7.1 Europe Huntington's Disease Therapeutics by Countries
7.1.1 Europe Huntington's Disease Therapeutics Sales by Countries
7.1.2 Europe Huntington's Disease Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Huntington's Disease Therapeutics by Product
7.3 Europe Huntington's Disease Therapeutics by End User

8 Asia Pacific
8.1 Asia Pacific Huntington's Disease Therapeutics by Countries
8.1.1 Asia Pacific Huntington's Disease Therapeutics Sales by Countries
8.1.2 Asia Pacific Huntington's Disease Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Huntington's Disease Therapeutics by Product
8.3 Asia Pacific Huntington's Disease Therapeutics by End User

9 Central & South America
9.1 Central & South America Huntington's Disease Therapeutics by Countries
9.1.1 Central & South America Huntington's Disease Therapeutics Sales by Countries
9.1.2 Central & South America Huntington's Disease Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Huntington's Disease Therapeutics by Product
9.3 Central & South America Huntington's Disease Therapeutics by End User

10 Middle East and Africa
10.1 Middle East and Africa Huntington's Disease Therapeutics by Countries
10.1.1 Middle East and Africa Huntington's Disease Therapeutics Sales by Countries
10.1.2 Middle East and Africa Huntington's Disease Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Huntington's Disease Therapeutics by Product
10.3 Middle East and Africa Huntington's Disease Therapeutics by End User

11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 Company Business Overview
11.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Products Offered
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Details
11.2.2 Company Business Overview
11.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 H. Lundbeck Huntington's Disease Therapeutics Products Offered
11.2.5 H. Lundbeck Recent Development
11.3 Prana Biotechnology
11.3.1 Prana Biotechnology Company Details
11.3.2 Company Business Overview
11.3.Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Prana Biotechnology Huntington's Disease Therapeutics Products Offered
11.3.5 Prana Biotechnology Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Company Business Overview
11.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Products Offered
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Horizon Pharma
11.5.1 Horizon Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Horizon Pharma Huntington's Disease Therapeutics Products Offered
11.5.5 Horizon Pharma Recent Development

12 Future Forecast
12.1 Huntington's Disease Therapeutics Market Forecast by Regions
12.1.1 Global Huntington's Disease Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Huntington's Disease Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Huntington's Disease Therapeutics Market Forecast by Product
12.2.1 Global Huntington's Disease Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Huntington's Disease Therapeutics Revenue Forecast by Product 2019-2025
12.3 Huntington's Disease Therapeutics Market Forecast by End User
12.4 North America Huntington's Disease Therapeutics Forecast
12.5 Europe Huntington's Disease Therapeutics Forecast
12.6 Asia Pacific Huntington's Disease Therapeutics Forecast
12.7 Central & South America Huntington's Disease Therapeutics Forecast
12.8 Middle East and Africa Huntington's Disease Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Huntington's Disease Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Huntington's Disease Therapeutics Product Picture
Table Huntington's Disease Therapeutics Market Segments
Table Key Manufacturers Huntington's Disease Therapeutics Covered
Table Global Huntington's Disease Therapeutics Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Huntington's Disease Therapeutics Sales Market Share by Product 2014-2025
Figure Antidopaminergics Product Picture
Table Major Manufacturers of Antidopaminergics
Figure Anticonvulsants Product Picture
Table Major Manufacturers of Anticonvulsants
Figure Antipsychotics Product Picture
Table Major Manufacturers of Antipsychotics
Figure Antidepressants Product Picture
Table Major Manufacturers of Antidepressants
Table Global Huntington's Disease Therapeutics Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospitals
Figure Clinics
Figure Diagnostic Centers
Figure Huntington's Disease Therapeutics Report Years Considered
Figure Global Huntington's Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Huntington's Disease Therapeutics Sales 2014-2025 (K MT)
Table Global Huntington's Disease Therapeutics Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Huntington's Disease Therapeutics Sales by Regions 2014-2019 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Huntington's Disease Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Huntington's Disease Therapeutics Sales Market Share by Regions
Table Global Huntington's Disease Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Huntington's Disease Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Huntington's Disease Therapeutics Revenue Market Share by Regions
Table Global Huntington's Disease Therapeutics Sales by Manufacturers (2014-2019) (K MT)
Table Global Huntington's Disease Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Huntington's Disease Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Huntington's Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Huntington's Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Huntington's Disease Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Huntington's Disease Therapeutics Price (2014-2019) (USD/MT)
Table Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Huntington's Disease Therapeutics Product Type
Table Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Global Huntington's Disease Therapeutics Sales Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Sales Market Share by Product in 2018
Table Global Huntington's Disease Therapeutics Revenue by Product (2014-2019) (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Revenue Market Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Revenue Market Share by Product in 2018
Table Huntington's Disease Therapeutics Price by Product 2014-2019 (USD/MT)
Table Global Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Global Huntington's Disease Therapeutics Sales Share by End User (2014-2019)
Figure Global Sales Huntington's Disease Therapeutics Market Share by End User (2014-2019)
Figure Global Sales Huntington's Disease Therapeutics Market Share by End User in 2018
Figure North America Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure North America Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table North America Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Sales Market Share by Countries
Table North America Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure United States Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure United States Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Canada Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table North America Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Market Share by Product
Table North America Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table North America Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Market Share by End User
Figure Europe Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Europe Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Europe Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Sales Market Share by Countries
Table Europe Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure Germany Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Germany Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure France Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure UK Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Italy Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Russia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Europe Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Market Share by Product
Table Europe Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Europe Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Market Share by End User
Figure Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Countries
Table Asia Pacific Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure China Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure China Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Japan Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Korea Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure India Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Australia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Market Share by Product
Table Asia Pacific Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Asia Pacific Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Market Share by End User
Figure Central & South America Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Central & South America Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Sales Market Share by Countries
Table Central & South America Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure Brazil Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Central & South America Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Market Share by Product
Table Central & South America Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Central & South America Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Market Share by End User
Figure Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Countries
Table Middle East and Africa Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure GCC Countries Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Market Share by Product
Table Middle East and Africa Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Market Share by End User
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development

Table H. Lundbeck Company Details
Table H. Lundbeck Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table H. Lundbeck Recent Development

Table Prana Biotechnology Company Details
Table Prana Biotechnology Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Prana Biotechnology Recent Development

Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development

Table Horizon Pharma Company Details
Table Horizon Pharma Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Horizon Pharma Recent Development

Table Global Huntington's Disease Therapeutics Sales Forecast by Regions 2019-2025 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Huntington's Disease Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Huntington's Disease Therapeutics Sales Forecast by Product 2019-2025 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share Forecast by Product 2019-2025
Table Global Huntington's Disease Therapeutics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Product 2019-2025
Table Global Huntington's Disease Therapeutics Sales Forecast by End User 2019-2025 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share Forecast by End User 2019-2025
Figure North America Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Huntington's Disease Therapeutics Value Chain
Table Huntington's Disease Therapeutics Customers List
Table Huntington's Disease Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory